Projects

A cross-sectional study of the prevalence, severity, and modifiable contributors to cancer-related fatigue, and the impact of standard palliative care intervention on the fatigue, functional status, and quality of life, in adult patients, in a tertiary care facility

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - 2026

Project Lead

Authors

Uttara Chari

Project Status

ongoing

Project Type

Unfunded